Compare GD & ELV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GD | ELV |
|---|---|---|
| Founded | 2019 | 1944 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Marine Transportation | Medical Specialities |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 86.9B | 78.9B |
| IPO Year | N/A | N/A |
| Metric | GD | ELV |
|---|---|---|
| Price | $341.60 | $338.01 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 18 | 16 |
| Target Price | $342.41 | ★ $392.47 |
| AVG Volume (30 Days) | 1.1M | ★ 1.5M |
| Earning Date | 10-24-2025 | 10-21-2025 |
| Dividend Yield | 1.76% | ★ 2.02% |
| EPS Growth | ★ 17.69 | N/A |
| EPS | 15.44 | ★ 24.39 |
| Revenue | $51,509,000,000.00 | ★ $194,820,000,000.00 |
| Revenue This Year | $12.01 | $13.21 |
| Revenue Next Year | $4.48 | $3.22 |
| P/E Ratio | $22.13 | ★ $13.87 |
| Revenue Growth | 11.86 | ★ 11.96 |
| 52 Week Low | $239.20 | $273.71 |
| 52 Week High | $360.50 | $458.75 |
| Indicator | GD | ELV |
|---|---|---|
| Relative Strength Index (RSI) | 50.07 | 57.57 |
| Support Level | $334.35 | $311.88 |
| Resistance Level | $343.06 | $341.89 |
| Average True Range (ATR) | 5.66 | 10.54 |
| MACD | -0.87 | 2.52 |
| Stochastic Oscillator | 37.39 | 90.56 |
General Dynamics is a defense contractor and business jet manufacturer. The firm's segments are aerospace, marine, combat systems, and technologies. General Dynamics' aerospace segment manufactures Gulfstream business jets and operates a global aircraft servicing operation. Combat systems produces land-based combat vehicles such as the M1 Abrams tank and Stryker armored personnel carrier, as well as munitions. The marine segment builds and services nuclear-powered submarines, destroyers, and Navy support ships. The technologies segment contains two main units: an IT business that primarily serves the government market and a mission systems business that focuses on products that provide command, control, computing, intelligence, surveillance, and reconnaissance capabilities to the military.
Elevance Health remains one of the leading health insurers in the US, providing medical benefits to 46 million medical members as of June 2025. The company offers employer, individual, and government-sponsored coverage plans. Elevance differs from its peers in its unique position as the largest single provider of Blue Cross Blue Shield branded coverage, operating as the licensee for the Blue Cross Blue Shield Association in 14 states. Through acquisitions, such as the Amerigroup deal in 2012 and MMM in 2021, Elevance's reach expands beyond those states through government-sponsored programs, such as Medicaid and Medicare Advantage plans, too. It is also an emerging player in pharmacy benefit management and other healthcare services.